INTRODUCTION
The remarkable fidelity of DNA replication and the predictable transmission of Mendelian traits sometimes appear to attenuate the fluidity of the genome. In humans, abundant polymorphie loci with multiple alleles, particularly those involving micro-or minisatellites, attest to the lubricious nature of certain sequences (8). However, the potential for genome instability has not been more apparent than with the recent discoveries of trinucleotide repeat expansion mutations.
Since 1991, 11 human loci, responsible for 9 genetic diseases, have been identified in which a normally polymorphic trinucleotide repeat undergoes a mutational change whereby the repeat length expands, sometimes quite remarkably (Table 1) . This dynamic mutation is unlike conventional mutations because the expanded repeat can undergo further change (usually continued expansion) with each subsequent generation. The magnitude of the expansion is, in part, related to the parental repeat length. For those expansions that result in a phenotype, the subsequent expansion of the repeat in descending generations can lead to non-Mendelian inheritance patterns due to incomplete penetrance and/or variable expressivity, which can generally be directly correlated with repeat length. Therefore the discovery of trinucleotide repeat expansions has uncovered a previously unrecognized form of mutational change and has provided a molecular explanation for some unusual inheritance patterns.
Loci that undergo trinucleotide repeat expansion can currently be placed within two groups based upon the involved repeat; either the CGG repeat (equally a CCG, the 5' sequence on the other strand) or the CAG repeat (alternatively CTG, again of the other strand). All four designations are used in the literature depending largely upon which strand is coding, if in the context of a gene. In addition, depending on the designation of the first base of a repeat tract, a GCC repeat, largely equivalent to a CCG or CGG repeat, may be reported. Alternatively, it has been argued that an alphabetical repeat nomenclature (CCG or AGC, for each repeat) be used (171) . However, repeat nomenclature used below reflects the predominant usage among investigators.
The CGG/CCG repeat loci involve noncoding (but sometimes transcribed) triplets and, when expanded, are associated with chromosomal fragile sites. The CAG/CTG repeats are most often coding and associated, when expanded, with neurodegenerative diseases. The exception is the 3' untranslated CTG repeat of myotonic dystrophy. The CTG repeat associated with myotonic dystrophy, like the CGG/CCG fragile site repeats, can undergo massive expansions from normal lengths of -30 repeats to several thousand when fully expanded, while the coding CAG repeats undergo a more modest two-to threefold increase over a normal length of-20 repeats. mosaicism of the expanded FMR1 trinucleotide repeat is common, with both premutation and multiple full mutation bands being observed in many affected males (49) . This has been interpreted as evidence for a postzygotic window of massive repeat expansion.
Concomitant with FMR1 trinucleotide repeat expansion into the full mutation range is methylation of both the CGG repeat as well as the nearby CpG island that correlates with the absence of FMR1 gene expression (73, 131, 167) . Normal alleles and premutation alleles remain unmethylated, consistent with findings of normal amounts of FMR1 mRNA and the encoded protein, FMRP (42) . Within the range of 200-300 repeats, methylation is the most sensitive indicator of penetrance (104, 113), although ribosome stalling on the expanded repeat within mRNA can lead to diminished protein levels (43) . Confirmation that the absence of FMR1 gene expression is responsible for the fragile X syndrome came with the identification of multiple patients with FMR1 deletions (133 and references therein) and a single point mutation (29), all in CGG repeat expansion-negative individuals. Also, an Fmrl knockout mouse exhibits features of fragile X syndrome, including enlarged testes, cognitive impairment, and hyperactivity (28).
Consistent with the absence of new mutations resulting in fragile X syndrome (159) , marked linkage disequilibrium suggests a small pool of founder chromosomes (129, 138) . Haplotyping of normal and fragile X chromosomes revealed distinct and unequal allelic frequencies among these two classes of chromosomes (95) . Through sequence analysis of normal FMR1 repeats, it has been shown that haplotypes normally containing repeats that are more nearly pure (less cryptic) tend to be overrepresented on fragile X chromosomes, suggesting that long perfect repeats are the predisposed, ancestral alleles (71, 95, 161) . Eichler et al (38) have shown that observable intergenerational instability correlates with uninterrupted repeats, 34-38 repeats in length. In addition, Kunst & Warren (95) have identified a distinct polarity of variation in CGG repeats, with all variation in length occurring on the 3' end of the repeat. Based on this observation, a model of trinucleotide repeat expansion due to slippage occurring during lagging strand synthesis of DNA replication has been proposed (95) .
The FMR1 gene consists of 17 exons spanning 38 kb of Xq27.3 (40) . Expression of the gene is widespread but not ubiquitous, with highest amounts of expression in brain, testes, and ovaries (2, 68, 69) . Alternative splicing producing multiple protein isoforms of 39-90 kD, some with novel carboxy termini, has been observed (10, 89, 181, 182) . Immunohistochemical analyses have revealed that FMRP is predominately cytoplasmic, although nuclear staining has occasionally been observed (32, 180) .
Two distinct ribonucleoprotein (RNP)-family motifs frequently found proteins that interact with RNA have been identified within the FMRP amino acid sequence (11, 156) . RNA-binding activity of FMRP toward RNA homopolymers and messenger RNA molecules has been documented, with FMRP interacting specifically with approximately 4% of messages present in human fetal brain (11, 157) . Protein products containing the lone FMRI missense mutation, Ile367Asn, display decreased levels of RNA-binding activity in vitro (155, 181) . Although the intracellular role of FMRP remains to elucidated, the recent association of FMRP with ribosomal subunits (DE Eberhart, Y Feng, F Zhang & ST Warren, submitted) suggests a possible role in translation.
Fragile X E (FRAXE)
When the diagnosis of fragile X syndrome incorporated testing for the FMR1 trinucleotide repeat expansion, a small group of families that were cytogenetitally positive for the fragile site but negative for FMR1 expansion was identiffed (14, 31) . Analysis of such families identified a second folate-sensitive fragile site, termed FRAXE, located 600 kb telomeric to FRAXA (FMR1) (46, 90, 168) . A highly polymorphic GCC repeat ranging from 7-35 repeats, with a mean of 15-16 repeats, was identified in normal individuals (4, 90, 91) . Repeats of 230-750 were observed in FRAXE-posifive individuals, and more modest repeats of 130-150 were found in carrier females who did not express FRAXE (90) . Reminiscent of fragile X syndrome, trinucleotide repeat expansions at the FRAXE locus of >150 repeats were correlated with abnormal methylation of a CpG island located approximately 1 kb upstream of the repeat, perhaps influencing a nearby gene (90) . It was observed that major FRAXE GCC repeat expansions occur more frequently upon maternal transmission, although, in contrast to FMR1, transmission of a large repeat from a male to his daughter has been documented (60) .
Some individuals displaying FRAXE expression display mild mental impairment, with IQ scores in the range of 60-80 (60, 91, 117) . Analogous to FMR1, phenotypic expression has been correlated with the degree of methylation of the nearby CpG island, as individuals with large GCC expansions at FRAXE, but only partial methylation, are phenotypically normal (117) . Penetrance FRAXE families is most often observed in individuals displaying >230 repeats (90) , similar in size to the FMR1 full mutation. Recently, deletions in the FRAXE region have been found in two unrelated individuals with developmental and speech delay, suggesting that the responsible gene for the FRAXE phenotype may reside in a 200-kb interval (51) .
Fragile X F (FRAXF)
A third folate-sensitive fragile site in the region of Xq27-Xq28 has recently been identified. This fragile site (FRAXF) was mapped at least 600 kb distal to FRAXE (70, 130) . A GCC trinucleotide repeat was subsequently identified at the FRAXF locus (130) . Normal repeat lengths ranged from 6-29 (130) , while individuals expressing the FRAXF fragile site displayed GCC repeat expansions of 300-1000 repeats together with concomitant methylation of the repeat region (130, 140) . Since FRAXF families without any noticeable phenotype exist (141, 168, 184) , it is possible that no genes reside near FRAXF, or that nearby methylation effects are without consequence.
Fragile 16 A (FRA16A)
Differential methylation was identified in individuals expressing the autosomal, folate-sensitive fragile site at 16p13.1 relative to controls, and corresponding YACs revealed a highly polymorphic CCG repeat at this locus (124) . Individuals expressing the FRA16A fragile site have large amplifications of the CGG repeat, ranging from 1000-1900 triplets (124) . Repeat sizes of normal Caucasian controls ranged from 16-49 triplets, with a mean of 22 (124) . Similar to FMR1, normal alleles with long uninterrupted repeats are believed to be predisposed toward instability (123) . Instability has been observed maternal transmissions of the FRA16A expansion and, unlike full expansions at FMR1, patemal transmission of the expansion occurs, but with little change in repeat length (123) . Importantly, Nancarrow et al (123) showed that while methylation of the region was present in FRA16A individuals, no methylation was observed in normal controls. These findings confirmed previous predictions at FMR1 that methylation seems to occur as a consequence rather than a cause of CGG repeat expansion (167, 169) . No phenotype has yet been associated with the FRA16A locus, although the lack of homozygous individuals could account for this observation.
Fragile 11 B (FRAllB)
The folate-sensitive fragile site FRAI1B, known to reside at 11q23.3 (170), has been characterized and linked to Jacobsen syndrome (82, 83). Jacobsen syndrome, involving dysmorphic features and severe mental retardation, is a chromosomal deletion syndrome with deletions in 1 lq (78, 150) . The FRAI1B fragile site and the breakpoints in a Jacobsen patient, whose mother expressed FRAllB, were recently colocalized (82, 83) near the protooncogene CBL2 (148, 177) , a gene previously shown to contain a CGG repeat in its 5' untranslated region (17, 139) . Jones et al (82) documented expansion of this repeat from the common repeat length of 11 triplets in normal chromosomes to repeat sizes >100 triplets in FRAllB-expressing individuals. Evidence of somatic mosaicism with multiple bands on Southern blots corresponding to a repeat range from 80 to >1000 has been observed (82). In another family, cytogenetically normal mother with 80 repeats had three FRAllB-expressing www.annualreviews.org/aronline Annual Reviews offspring all with repeat lengths in excess of 100; this suggests the existence of premutations similar to that described for FMR1. Also similar to FMR1, there is evidence for abnormal methylation in the vicinity of the expanded FRAllB repeat (82) .
In three of eight families displaying 1 lq23 deletions and Jacobsen syndrome, expansion of the GCC repeat of CBL2 has been documented, consistent with the possibility that the inherent instability of the expanded CBL2 GCC repeat could predispose toward deletions resulting in Jacobsen syndrome (82) . Therefore, these data resurrect the possibility that fragile sites may influence nonrandom chromosome rearrangements, particularly those involving cancer (199) . It is not known, in this instance, if CBL2 is inactivated by abnormal FRA11B methylation. However, since CBL2 is a dominant oncogene rather than a tumor suppressor, hemizygous expression of CBL2 may not predispose toward cancer.
NEURODEGENERATIVE DISORDERS AND CAG/CTG REPEATS

Spinal and Bulbar Muscular Atrophy (SBMA)
Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease (88) , is an X-linked recessive, adult-onset motor neuropathy (97) . Affected individuals typically present in the 3rd to 5th decade with motor neuron signs such as proximal muscle weakness and fasciculations, as well as signs of bulbar muscle dysfunction such as dysphagia (96) . In addition, affected males often display signs of mild androgen insensitivity, including gynecomastia, reduced fertility, and testicular atrophy (96) . Autopsies of affected individuals revealed diffuse lower motor neuron degeneration as well as loss of brainstem motor nuclei corresponding to the trigeminal, facial, and hypoglossal nerves (162) .
In 1991, the SBMA disorder was colocalized to Xql2 with the androgen receptor (AR) gene (45) . The AR gene contains a trinucleotide repeat within the first exon that encodes a polyglutamine tract. This normally polymorphic CAG repeat of 11-33 repeats undergoes expansion to 38-66 repeats in SBMA patients (16) . Repeats within the normal range were meiotically stable in all transmissions, whereas instability was observed in 27% of transmissions of expanded CAG alleles (96) . Both contractions and expansions of the AR repeat have been observed, with expansions occurring in >75% of cases (15, 96) . Analysis of normal sperm has revealed a CAG repeat mutation rate of 6.7 x 10-3; however, sperm of an affected individual (47 repeats) showed 60% expansions and 15% contractions (202, 203) . Strong correlations between repeat length and age of onset (35, 75, 96) have been documented.
The effect of polyglutamine lengthening in the AR protein is currently www.annualreviews.org/aronline Annual Reviews unknown. Although gynecomastia, testicular atrophy, and sterility as well as decreased androgen binding are consistent with androgen insensitivity, these patients are phenotypic males. This is in marked contrast to XY individuals with testicular feminization who are phenotypic females because of the absence or inactivity of the AR protein (108) . Furthermore, the absence of SBMA-type neurodegenerative changes in individuals with testicular feminization or severe androgen insensitivity suggests a novel activity of the AR with an expanded polyglutamine tract that is not present in normals or individuals with null alleles. Since the AR is a transcription factor, one hypothesis is that polyglutamine expansion alters gene expression, thus leading to neuron degeneration (114) . Altered transcriptional activation by AR proteins with expanded repeats has been found and interpreted to suggest that the polyglutamine expansion leads both to a partial loss-of-function, leading to incomplete androgen insensitivity, as well as a gain-of-function that is selectively motor neurotoxic (86, 114) .
Spinocerebellar Ataxia, Type 1 (SCA1)
Spinocerebellar atrophy, type 1 (SCA1), is an autosomal dominant neurodegenerative disease characterized by progressive limb and gait ataxia, dysarthria, dysphagia, opthalmoparesis, muscle wasting, and peripheral neuropathy (143) . Neuropathologic features include loss of Purkinje cells of the cerebellar cortex, atrophy of the brainstem, and neuronal loss in the cerebellum, brainstem, and spinocerebellar tracts (204) . The range of onset can be from 4-70 years within a single family, with juvenile onset cases being observed in the later generations indicative of genetic anticipation (205) . Orr et al (127) identified a CAG repeat at the SCA1 critical region on chromosome 6. Repeat sizes within the normal population ranged from 6-39 repeats, while repeats of 41-81 were observed in affected patients (112) . inverse correlation between repeat length and age of onset has been documented, as well as a strong direct correlation between repeat length and severity of disease (81, 134) . All cases of juvenile onset SCA1 occur through paternal transmissions of expanded repeats in excess of 58 repeats (127) . Chung et (27) reported that in 16 paternal transmissions observed, 63% resulted in CAG expansion in the next generation, whereas in 28 maternal transmissions, 69% of the CAG repeats either decreased or remained the same size.
The CAG repeat of SCA1 is a cryptic repeat in the normal population, with two interrupting CAT triplets (CAG-repeat positions 13 and 15) being observed in 98% of normal alleles analyzed (27). However, no interruptions are present within the expanded alleles, suggesting that loss of the interrupting CAT triplets could account for the instability observed in SCA1 families.
The SCAI gene is comprised of nine exons covering 450 kb of the human www.annualreviews.org/aronline Annual Reviews genome (12) . The transcript is 10,660 nucleotides in length with expression in all tissues analyzed (12, 127) . A 2448-nucleotide open reading frame encodes a predicted 87-kD polypeptide of unknown function, referred to as ataxin-l, that contains a polymorphic polyglutamine tract interrupted by two histidine residues (corresponding to the CAT interruptions of the CAG repeat) (12) . The remainder of the message is a 936-base 5' untranslated region (UTR) and a uniquely large 3' UTR of 7277 nucleotides (12) . Immunohistochemical analyses detect both wild-type and mutant ataxin-1 in extracts of cultured cells from $CA1 patients, indicating that proteins with expanded CAG repeats are expressed within the cell (151) . Additionally, subcellular localization studies have revealed that ataxin-1 exhibits predominately nuclear staining in neuronal cells, cytoplasmic staining in skeletal muscle, and both cytoplasmic and nuclear staining in Purkinje cells (151 
Huntington's Disease (HD)
Huntington's disease (HD) is an autosomal dominant movement disorder affecting approximately 1 in 10,000 Caucasians (65) . The disorder is characterized by neuronal loss in the caudate and putamen, primarily of medium spiny neurons (58, 67) . Characteristic features include progressive cognitive decline and chorea, which typically become manifest in midlife but which can occur anytime between ages 2 and 90 (58) . An unstable CAG repeat in HD patients, encoding a polyglutamine tract in the IT15 gene, was reported in 1993 (57) . Repeat lengths in affected individuals from numerous ethnic groups ranged from 36-121 (av 44-45), expanded from normal repeat lengths of 10-35 (av 18-19) (6, 36, 93, 160) . Both repeat expansions and reductions were observed, with expansions being much more frequent in the paternal lineage, consistent with predominant paternal transmission in juvenile onset cases (3, 58, 160, 206) . Strong correlations in age of onset or disease progression and repeat length have been obtained (6, 76, 105) .
Repeat sizes within the range of 30-38 are exceedingly rare, (93, 135) . The identification of multiple families with apparently sporadic HD in which an expanded HD chromosome was inherited from an unaffected individual with a repeat size of 30-38 in length has lead to speculation that an intermediate class of alleles analogous to the premutation alleles of fragile X syndrome may exist (53, 54, 118) . Expansions of intermediate alleles resulting in de novo expression of HD have been confined exclusively to paternal transmissions (53, 54, 118) . Consistent with paternal instability, marked heterogeneity repeat size has been shown in sperm of affected HD males (36, 106, 174) .
The human HD gene (1T15) encompasses 180-200 kb and consists of 67 exons (5). IT15 expression is found throughout the brain as well as in other somatic tissues (57, 101, 166) . The 348-kD protein, referred to as huntingtin, is of unknown function and is predominately cytoplasmic (33, 72, 152, 175) . Expression of both normal and expanded IT15 transcripts and protein has been documented (84, 164) , indicating an enlargement of the huntingtin protein the expanded polyglutamine tract. Disruption of the murine Hdh gene produces embryonic lethality in homozygotes (37, 125) .
Dentatorubral-Pallidoluysian
Atrophy (DRPLA Autosomal dominant, dentatorubral-pallidoluysian atrophy (DRPLA) occurs with an estimated prevalence of 1 in 1 million in Japan (115), with rare occurrences in Europe and North America (132, 188, 189) . DRPLA is named for the neuropathological findings of atrophy of the dentate nucleus of the cerebellum and its projections to the red nucleus (rubro) combined with atrophy of the lateral segment of the globus pallidus and its projections to subthalamic nuclei (of Lnys) (121, 158, 172) . DRPLA is similar to HD and is characterized cerebellar ataxia, ehoreoathetosis, and dementia, although patients < 20 years old show progressive myoclonic epilepsy and mental retardation (92, 172) . Koide et al (92) and Nagafuchi et al (120) , through screening of databases for CAG repeat-containing sequences, each independently identified a CAGcontaining sequence, known as B37, originally identified by Li et al (100) and mapped to human chromosome 12, where DRPLA localized. CAG repeat sizes range from 7-25 pure repeats in the normal population, with expansion to 49-75 repeats in affected individuals (92, 120) . Consistent with other trinucleotide repeat diseases, larger expanded repeats have been correlated with more severe phenotypes and/or earlier age of disease onset (92, 120) . Somatic variation in CAG repeat length between various brain structures has recently been documented (178) . Repeat expansions are more frequently observed paternal transmissions (92, 120, 147) .
The gene for DRPLA encodes a 4.5-kb transcript expressed in all tissues, with highest levels in brain, ovary, testis, and prostate (119) . The predicted polypeptide is 1184 amino acids in length and contains a polyglutamine tract corresponding to the CAG repeat (119) . Antibodies against the predicted DRPLA protein detect an enlarged protein product in the brains of DRPLA patients (197) , consistent with the expanded polyglutamine tract.
HAW RIVER SYNDROME Haw River syndrome (HRS) is an autosomal dominant neurodegenerative disorder found in a single African-American family www.annualreviews.org/aronline Annual Reviews from Haw River, North Carolina (41) . Phenotypie manifestations and neuropathologic findings are similar to DRPLA, but HRS differs from DRPLA in that myoclonus is not observed in the HRS family (22) . Burke et al (22) showed that the DRPLA trinucleotide repeat was expanded in members of this HRS family. Therefore, the same CAG repeat expansion accounted for both DRPLA and HRS, with 63-68 triplets found in HRS, similar to DRPLA (22) . Although not an allelic variant of DRPLA, HRS may represent the influence of different alleles of a modifying gene(s).
A comparison of normal DRPLA repeat alleles in African-American, American-Caucasian, and Japanese populations has revealed that normal alleles in excess of 19 repeats are most common (7.4%) in the Japanese population, compared to 1% and 0% for the African-American and Caucasian, respectively, implying that the presence of larger CAG alleles might account for the increased prevalence of disease in the Japanese and rarely in African-Americans populations (21) .
Machado-Joseph Disease (MJD/SCA3)
The disease most recently added to the rapidly growing list of disorders caused by unstable trinucleotide repeats is Machado-Joseph disease (MJD, now also known as spinocerebellar ataxia type 3; SCA3). Initially described in individuals of Portuguese-Azorean descent (122, 144) , MJD is now rec-0gnized as a common cause of spinocerebellar degeneration in individuals of most ethnic origins (85, 142) . Degenerative changes have been noted neurons of the substantia nigra, dentate nucleus of the cerebellum, neurons of the spinocerebellar and pyramidal tracts of the spinal cord, and peripheral neurons (142, 163) . Clinically, these changes in both the central and peripheral nervous systems are observed as cerebellar ataxia, extrapyramidal features such as dystonia-rigidity reminiscent of parkinsonism, peripheral neuropathy, facial and lingual fasciculation, and external ophthalmoplegia (142, 163) . Kawaguchi et al (85) have recently identified a gene mapping to 14q32.1 within the MJD linkage interval that contains a CAG trinucleotide repeat observed to be unstable in MJD families. The gene, termed MJD1, encodes a predicted 359-amino acid protein of unknown function. The unstable CAG repeat ranges from 12-37 repeats in normal controls with expansion to 61-84 repeats in MJD patients (107, 111) . Expansion of the CAG repeat within both maternal and paternal lineages has been found, with the greater increase in repeat length being noted in paternal transmissions (111) . An interruption the CAG repeat at the 5' end of the repeat has been observed in all patients and controls, with all variation in repeat size occurring on the 3' end of the repeat (85).
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Myotonic Dystrophy (DM)
Autosomal dominant myotonic dystrophy (DM) is the most common form adult muscular dystrophy (18) . Clinical features of the DM disorder include myotonia, progressive muscular weakness and wasting, cardiac conduction abnormalities, and cataracts, with frontal balding and testicular atrophy in affected males (18) . The phenotype is quite variable, ranging from only cataracts or balding in mildly affected individuals with adult-onset DM to severe hypotonia, muscular atrophy, and mental retardation in congenital DM (176) . Genetic anticipation in DM families had been clearly documented with the milder phenotype occurring in earlier generations (64, 74) .
DNA fragments in the region of human chromosome 19q13.3 were identified that displayed length variation in DM patients (18, 23, 50, 62, 109) . This length variation was mapped to a normally polymorphic CTG trinucleotide repeat that exists as 5-37 copies in the normal Caucasian population, with expansions from 50 to >3000 in affected patients (18, 50, 99, 109) . The extent of trinucleotide repeat expansion is in direct correlation with disease severity (18, 23, 99, 109) . Individuals with intermediate-sized repeats, between 50-80, display very mild phenotypes, if any (20, 25) . The distribution of normal CTG repeat lengths in the DM gene of Caucasians is trimodal, with peaks at 5 (35-40%), 11-17 (50%), and 19-30 (10%) (77, 201) . The normal DM in Southern African populations range from 5-22 repeats, and this reduction of large normal repeats has been correlated with marked decreases in DM prevalence in this population (55) . In the Caucasian population, linkage disequilibrium between a nearby 1-kb Alu insertion/deletion polymorphism and DM has been established (77, 98) , and it has been suggested that the class 19-30 repeats might represent a pool of predisposed normal alleles (77) .
Individuals displaying congenital DM and their mothers display larger repeat amplifications than noncongenital DM affecteds (63, 176) . Although the overall trend in CTG instability is toward amplification, reductions in the expanded CTG repeat in paternal transmissions have been described (1, 9, 19, 30) . Two "reverse" mutations have been reported in which expanded alleles in affected male individuals contracted to 19 and 24 repeats in phenotypically normal offspring (19) .
Tissue-specific somatic mosaicism of CTG repeat length has been reported, in favor of a postzygotic window of trinucleotide repeat expansion in DM (7, 80, 116, 196, 200) . Repeat sizes in muscle tissue exceed that in peripheral lymphocytes in DM patients (7, 200) . Age-dependent mosalcism in DM affecteds has also been described, with increasing variation in somatic cell repeat size skewed toward expansion rather than contraction in DM individuals who have been followed over time (196, 200) . Variation in repeat sizes in sperm included both expansions and contractions, with the tendency toward expan-www.annualreviews.org/aronline Annual Reviews sion observed only in those individuals with small or intermediate-sized repeats (80) . Contractions of the DM repeat in sperm into the normal range were observed, whereas expansions >I000 repeats have not been reported, accounting for both the occurrence of reverse mutations in paternal transmissions as well as the predominately maternal transmission of congenital cases of DM, respectively (80) .
The aberrantly expanded CTG repeat of DM resides in the 3' untranslated region of a serine/threonine protein kinase referred to as DM protein kinase (DMPK) (18, 50, 109) . The DM gene consists of 15 exons spanning approximately 14 kb (110) . The gene is expressed most highly in skeletal and cardiac muscle (79) . Immunohistochemical studies have localized a 69-kD DM protein to the neuromuscular junction of skeletal muscle as well as to intercalated disks in cardiac muscle (179, 193) . The effect of trinucleotide repeat expansion within the DM gene on expression of DMPK remains controversial. Although Carango et al (24) reported decreased expression from expanded alleles, conflicting reports of both decreased (48) as well as increased (146) expression of DM mRNA exist. Consistent with down-regulation of the abnormal DM allele, expanded CTG repeats of the DM gene have recently been demonslrated to be sites of preferential nucleosome assembly, with increasing repeat lengths directly correlated with more vigorous nucleosome assembly (186, 187) . Altered chromatin structure associated with DM trinucleotide repeat expansion has also been documented, consistent with the apparently disproportionate levels of DM allele expression (128) . More recently, unusual nuclear sequestration of DM messages with expanded CTG repeats has been reported from both muscle biopsies and fibroblasts of affected individuals (173) . Wang et (185) observed decreased accumulation of the entire poly A+ RNA pool muscle biopsy specimens from DM affecteds, suggesting that the expanded CTG repeat could represent a trans-factor that has a dominant-negative effect on multiple cellular RNAs.
CONCLUSIONS
General Features of Expansion Mutations
While there are no obvious intrinsic reasons for trinucleotides to participate in expansions (compared, for example, to di-or tetranucleotides), the commonality of all 11 loci being CG-rich trinucleotide repeats certainly suggests a bias toward this type of repeat. Also without obvious explanation is the limitation of this form of mutation to the human species. However, studies of expansion-prone human loci in other species suggest a tendency in nonhumans toward smaller repeats or cryptic repeats, both of which would presumably stabilize the triplet repeat (10, 13, 39, 102 ). It has been proposed that these smaller, cryptic repeats tend to increase in length and purity through evolution, suggesting that humans are intrinsically at higher risk for this form of mutation (39, 145) . However, the failure of human tmnsgenes containing long, previously unstable trinucleotide repeats to exhibit instability in the mouse (16) could indicate species differences in DNA replication/repair that influence repeat instability. Alternatively, such transgenic data could be explained by the absence of critical cis-acting elements from the cDNA constructs used. If certain cis-acting sequences are critical for expansion, the orthogenous loci may lack this critical genomic organization.
The expansion mutations characterized to date can be categorized by those undergoing short expansions (2-3 times normal repeat length) versus those that undergo long expansions (>10 normal repeat length). All coding CAG repeat loci fall within the former classification while those involving fragile sites and the myotonic dystrophy locus are long repeat expansions. However, the latter group do exhibit short expansion phenomena. For example, the premutation alleles at the FMR1 locus behave similarly to the short expansions of the coding CAG repeat loci. Since evidence suggests that the long expansions are postmeiotic events, occurring in early embryogenesis (80, 116, 195) , a congruent possibility is that all the loci exhibit a meiotic short expansion mutational mechanism, which at certain loci, may undergo continued expansion mitotically in the early embryo. This notion is attractive because it is consistent with data from both long and short expansion loci indicating that purity of the repeat (27, 95), promotes instability (seen particularly in pure tracts of >38 trinucleotides) (39) , and it also accounts for the mosaicism common with the long expansions. Therefore, there may be a similar meiotic mechanism operating at all these loci where long perfect repeat tracts are inherently unstable. Mechanisms have been proposed suggesting that such reiterated tracts could lead to lagging strand instability, since 38 trinucleotides approximate the length of an Okazaki fragment (95, 137) . Alternatively, it has been proposed that the trinucleotide repeats form unusual DNA structures that confer instability (26, 47) .
Also consistent among most of these disorders is a parent-of-origin effect. While most of the CAG repeat loci show a clear paternal bias for expansion, fragile X syndrome and DM exhibit a maternal origin for large expansion. While the former is likely a meiotic event, the latter may involve a maternal imprint.
Consequences of Trinucleotide Repeat Expansion
The consequence of trinucleotide repeat expansion appears to be based upon the specific repeat, the length of the expansion, and the location of the repeat within the genome. The CGG/CCG repeats, which, unlike the CAG repeats, www.annualreviews.org/aronline Annual Reviews contain a methylatable CpG dinucleotide, acquire heavy DNA methylation once the repeat length exceeds approximately 200 trinucleotides. This methylation appears to be in response to the long repeat since there is evidence that expansion precedes methylation (167) or is normally not observed at a given locus except in the presence of an expanded repeat (82, 124) . How expanded CGG/CCG repeats acquire DNA methylation is unclear. However, long reiterated sequences may be viewed as foreign by the cell, which then may attempt to inactivate the repeat by methylation, similar to the acquisition of methylation by integrated viral genomes (34). Once the lengthy CGG/CCG repeats become methylated, they appear to replicate later in the cell cycle (61) , which may therefore be the molecular basis of the cytogenetic fragile sites. The long, methylated CGG/CCG repeats also influence gene expression, as is the case with FMR1, and can therefore impart a loss-of-function phenotype if in the vicinity of a gene. There is evidence of yet uncharacterized human repeat loci that can frequently expand without apparent phenotypic consequence (149), suggesting, as have others (139) , that many more examples of trinucleotide repeat expansion will be found. The consequences of the CAG repeat expansions appear to be at the level of the protein. These expansions are thought to confer a gain or altered function rather than a loss-of-function. The polyglutamine tracts encoded by the normal CAG repeat, which double or triple in length in proteins encoded by the expanded alleles, have been speculated to become substrate for transglutaminases and cross-link to lysyl donor proteins (56), oligomerize with themselves or other polyglutamine-containing proteins (165) , or alter transcriptional activation for the nuclear proteins (52) . Irrespective of the ultimate mechanism, all coding CAG repeat disorders share a remarkable feature of neuronal degeneration and, therefore, whatever the change induced by the expanded polyglutamine, it likely will influence programmed cell death to some degree.
The consequence of the CTG expansion in myotonic dystrophy is less clear. RNA processing has generally been implicated, even in conflicting studies, and is somewhat appealing given the location of the repeat within the 3' UTR and the emerging importance of 3' UTRs in RNA processing (87) . However, the presence of another gene near the DMPK repeat (79) , which could also contribute to the phenotype, confounds the understanding of the consequence of the CTG expansion.
One feature of the trinucleotide repeat expansions that is clearly apparent is the presence of genetic anticipation in affected pedigrees (66) . The correlation of repeat expansion with the decreasing age of onset in coding CAG expansions, with the increasing penetrance in fragile X syndrome, and with the increasing disease severity in myotonic dystrophy, is striking. All of these phenomena, which can be grouped as genetic anticipation, influence or modify to varying degrees the expected Mendelian inheritance patterns and had been previously explained, when not dismissed outright as ascertainment errors (66) 
